DexCom Inc

2 Nov 2026, 23:31 UTC

Dexcom Inc shares are advancing in after-market hours, supported by stronger-than-expected ISM Manufacturing PMI data, despite mixed economic signals and geopolitical volatility.

30 Oct 2026, 23:16 UTC

JP Morgan maintains Neutral rating on Dexcom Inc and raises its price target to $85, reflecting the company's market position and growth potential.

29 Oct 2026, 23:02 UTC

Dexcom Inc reported Q3 revenue of $1.344 billion, exceeding estimates, and raised fiscal year 2026 revenue guidance to $5.20-$5.25 billion.

28 Oct 2026, 20:52 UTC

Dexcom Inc is advancing in after-market trading, supported by a notable increase in the Health Care Equipment sub-sector.

27 Oct 2026, 19:36 UTC

Dexcom Inc is trading modestly higher, having fluctuated earlier in the session before pulling back from its mid-morning peak.

22 Oct 2026, 20:02 UTC

Dexcom Inc shares are declining, reversing a trend of higher daily closes observed since Wednesday's close.

21 Oct 2026, 20:01 UTC

Dexcom Inc shares fell sharply, marking a downward shift and diverging from the recent trend of higher daily closes.

20 Oct 2026, 20:08 UTC

Dexcom Inc shares are declining, pulling back from an earlier session high, and have dropped slightly since Monday's close.

19 Oct 2026, 20:07 UTC

Dexcom Inc shares are declining, showing a slight drop since Friday's close amid routine market movement within the midpoint of its one-month trading range.

16 Oct 2026, 23:06 UTC

Dexcom Inc shares are advancing modestly in after-market trading following Friday's close, currently positioned within the middle of its one-month trading range.

15 Oct 2026, 20:02 UTC

Dexcom Inc shares advanced sharply after the CONNECT study showed significant A1C reduction and improved glucose target range for users of the Dexcom G7.

14 Oct 2026, 23:01 UTC

Dexcom's stock advanced in after-market trading following the CONNECT study publication, showing the G7 lowers A1C levels by an average of 1.6% for Type 2 diabetes patients.

13 Oct 2026, 19:53 UTC

Dexcom Inc shares are declining amid significant downward movement in the Health Care Equipment sub-sector, currently positioned near the lower end of its one-month range.

12 Oct 2026, 19:16 UTC

BTIG reiterates Buy rating on Dexcom Inc and raises price target to $96, according to a report released earlier today.

8 Oct 2026, 19:15 UTC

Dexcom Inc shares are trading roughly flat, with a slight cumulative return since Wednesday's close, amid broader market weakness.

7 Oct 2026, 23:55 UTC

Dexcom Inc's shares have declined in after-market trading, settling lower after an early high and remaining below their 20-day moving average.

6 Oct 2026, 20:00 UTC

Dexcom Inc shares fell sharply, breaking a trend of higher daily closes established since Monday, amid a decline contrasting recent upward momentum.

5 Oct 2026, 20:06 UTC

Dexcom Inc. is trading higher today, reflecting a generally positive market environment following an early dip and steady rise in broader market activity.

2 Oct 2026, 20:07 UTC

Dexcom Inc's shares are declining, pulling back from earlier gains and trading below their 20-day moving average amid Friday's session.

30 Sept 2026, 20:07 UTC

Dexcom Inc shares fell lower Wednesday, following a modest decline from Tuesday's close, despite briefly peaking earlier in the session.

25 Sept 2026, 20:07 UTC

Dexcom Inc shares fell sharply, continuing a downward trajectory and closing lower compared to Thursday, remaining below its 20-day moving average.

23 Sept 2026, 20:07 UTC

Dexcom Inc shares fell sharply after an earlier rise, reflecting a decline compared to Tuesday's close amid broader market weakness.

22 Sept 2026, 20:07 UTC

Dexcom Inc is seeing a modest gain, reflecting stability near the upper end of its one-month range and above its 20-day moving average.

18 Sept 2026, 20:07 UTC

Dexcom Inc shares are advancing as Truist Securities raised its price target to $102 and TD Cowen reiterated its Buy rating with a $95 target.

17 Sept 2026, 19:26 UTC

Dexcom's stock is higher as Truist Securities raises its price target to $102.00 from $93.00, maintaining a Buy rating.

16 Sept 2026, 20:10 UTC

Dexcom Inc is trading higher, reaching a peak in late morning and settling above Tuesday's close, marking three consecutive daily gains.

15 Sept 2026, 20:01 UTC

Dexcom Inc shares are trading higher amid broader market concerns following a significant decline in the NY Empire State Manufacturing Index.

10 Sept 2026, 19:36 UTC

Dexcom Inc shares are higher in Thursday's session, recovering from an initial dip. The stock remains below its 20-day moving average. No specific news identified.

9 Sept 2026, 22:11 UTC

Dexcom Inc shares are higher in after-market trading, reflecting a positive shift since Wednesday's close, despite recent lower closes and no specific news.

8 Sept 2026, 20:01 UTC

Dexcom Inc. shares are lower today, trading significantly below their 20-day moving average amid speculation of a potential Federal Reserve interest rate hike.